Chargement en cours...

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

We have achieved significant improvement of ornithine transcarbamylase deficiency (OTCD) in a mouse model through adenoviral-mediated gene transfer of the human ornithine transcarbamylase cDNA. Substantial reduction in orotic aciduria was observed within 24 h of treatment. Metabolic correction was l...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Morsy, M A, Zhao, J Z, Ngo, T T, Warman, A W, O'Brien, W E, Graham, F L, Caskey, C T
Format: Artigo
Langue:Inglês
Publié: 1996
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC507121/
https://ncbi.nlm.nih.gov/pubmed/8609240
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!